ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59 | -6.3% | 39,684 | +0.8% | 0.00% | – |
| Q2 2023 | $63 | -45.2% | 39,370 | -0.6% | 0.00% | – |
| Q1 2023 | $115 | -40.7% | 39,589 | -33.0% | 0.00% | – |
| Q4 2022 | $194 | -99.9% | 59,104 | -0.1% | 0.00% | – |
| Q3 2022 | $224,000 | -51.2% | 59,175 | +0.4% | 0.00% | -100.0% |
| Q2 2022 | $459,000 | -23.4% | 58,920 | -8.6% | 0.00% | 0.0% |
| Q1 2022 | $599,000 | -34.2% | 64,445 | +11.5% | 0.00% | 0.0% |
| Q4 2021 | $911,000 | -12.2% | 57,781 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,038,000 | -6.0% | 57,974 | -18.3% | 0.00% | 0.0% |
| Q2 2021 | $1,104,000 | +9.3% | 70,967 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $1,010,000 | -26.8% | 70,300 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,380,000 | +102.3% | 70,300 | +33.7% | 0.00% | +100.0% |
| Q3 2020 | $682,000 | -11.0% | 52,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $766,000 | +84.6% | 52,600 | +7.8% | 0.00% | 0.0% |
| Q1 2020 | $415,000 | -48.4% | 48,800 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $804,000 | +16.7% | 48,800 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $689,000 | -21.8% | 48,800 | +11.4% | 0.00% | 0.0% |
| Q2 2019 | $881,000 | -49.4% | 43,800 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $1,741,000 | +21.7% | 43,800 | +6.3% | 0.00% | 0.0% |
| Q4 2018 | $1,431,000 | -27.6% | 41,200 | -13.8% | 0.00% | 0.0% |
| Q3 2018 | $1,977,000 | +19.0% | 47,800 | +5.8% | 0.00% | 0.0% |
| Q2 2018 | $1,661,000 | +19.3% | 45,200 | +26.6% | 0.00% | 0.0% |
| Q1 2018 | $1,392,000 | +156.4% | 35,700 | +19.0% | 0.00% | +100.0% |
| Q4 2017 | $543,000 | +32.8% | 30,000 | +21.5% | 0.00% | 0.0% |
| Q3 2017 | $409,000 | +18.2% | 24,700 | 0.0% | 0.00% | – |
| Q2 2017 | $346,000 | -31.9% | 24,700 | -0.0% | 0.00% | -100.0% |
| Q1 2017 | $508,000 | +44.7% | 24,701 | +0.0% | 0.00% | – |
| Q4 2016 | $351,000 | -33.5% | 24,700 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $528,000 | +6.2% | 24,700 | +11.8% | 0.00% | 0.0% |
| Q2 2016 | $497,000 | +44.5% | 22,100 | +22.1% | 0.00% | 0.0% |
| Q1 2016 | $344,000 | -28.0% | 18,100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $478,000 | -3.2% | 18,100 | +15.3% | 0.00% | 0.0% |
| Q3 2015 | $494,000 | -22.4% | 15,700 | +30.0% | 0.00% | 0.0% |
| Q2 2015 | $637,000 | – | 12,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |